Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Tanabe, Kenneth
Item TypeName
Academic Article Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus.
Academic Article The effect of ganciclovir on herpes simplex virus-mediated oncolysis.
Academic Article Influence of p53 on herpes simplex virus type 1 vectors for cancer gene therapy.
Academic Article Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil.
Academic Article Regulation of herpes simplex virus 1 replication using tumor-associated promoters.
Academic Article Viral oncolysis.
Academic Article Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen.
Academic Article Oncolysis by viral replication and inhibition of angiogenesis by a replication-conditional herpes simplex virus that expresses mouse endostatin.
Academic Article Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector.
Academic Article Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis.
Academic Article Viral oncolysis by herpes simplex virus and other viruses.
Academic Article Angiogenesis inhibition using an oncolytic herpes simplex virus expressing endostatin in a murine lung cancer model.
Academic Article An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma.
Academic Article Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.
Academic Article Mouse models of subcutaneous spleen reservoir for multiple portal venous injections to treat liver malignancies.
Academic Article Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liver.
Academic Article Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice.
Academic Article Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene.
Academic Article Positron emission tomography of herpes simplex virus 1 oncolysis.
Academic Article Oncolytic herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation.
Concept Simplexvirus
Grant Targeting diffuse liver metastases with Herpes virus
Grant Phase I clinical trial of viral oncolysis of liver tumo*
Academic Article Phase II efficacy results using an oncolytic herpes simplex virus (NV1020) in patients with colorectal cancer metastatic to liver (mCRC).
Academic Article Tumor efficacy of an oncolytic herpes simplex virus (NV1020) in patients with colorectal cancer metastatic to liver (mCRC).
Search Criteria
  • Simplexvirus
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.